No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adalimumab
-
Adult
-
Animals
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Arthritis, Psoriatic / drug therapy*
-
Etanercept
-
Female
-
Guideline Adherence*
-
Humans
-
Immunoglobulin G / therapeutic use
-
Infliximab
-
Male
-
Middle Aged
-
Practice Guidelines as Topic
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Treatment Failure
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
United Kingdom
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
golimumab
-
Infliximab
-
Adalimumab
-
Etanercept